Cancer Drug Resistance is selected to be included in Emerging Sources Citation Index(ESCI)

Published on: 20 Aug 2022 Viewed: 984

We are pleased to announce that Cancer Drug Resistance (CDR, 2578-532X (Online)) journal has been accepted for inclusion in the Emerging Sources Citation Index (ESCI).

The inclusion of Cancer Drug Resistance means that papers published on CDR will be searchable on the Web of Science with full citation counts, author information, and other rich content.

In the future, OAE Publishing Inc. will continue to follow the strict and standard peer-review rules to ensure high-quality publications and strive to develop CDR into a journal with more international influence.